1. Home
  2. AUPH vs MEG Comparison

AUPH vs MEG Comparison

Compare AUPH & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.61

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$22.83

Market Cap

930.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
MEG
Founded
1993
2012
Country
Canada
United States
Employees
N/A
3500
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
930.8M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
AUPH
MEG
Price
$15.61
$22.83
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
$17.25
$35.25
AVG Volume (30 Days)
1.1M
294.0K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
5075.00
93.69
EPS
2.07
N/A
Revenue
$283,055,000.00
$830,538,000.00
Revenue This Year
$16.53
$5.46
Revenue Next Year
$16.24
$7.10
P/E Ratio
$7.54
N/A
Revenue Growth
20.38
19.26
52 Week Low
$6.83
$10.51
52 Week High
$16.54
$32.00

Technical Indicators

Market Signals
Indicator
AUPH
MEG
Relative Strength Index (RSI) 63.24 46.35
Support Level $14.56 $21.11
Resistance Level $16.28 $23.78
Average True Range (ATR) 0.53 1.07
MACD 0.15 -0.10
Stochastic Oscillator 95.73 41.37

Price Performance

Historical Comparison
AUPH
MEG

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

Share on Social Networks: